
Catalog Advanced Search
-
Contains 3 Component(s)
Learn how advanced practitioners (APs) can integrate clinical research into their daily practice and explore the various roles they can take on, such as principal or co-investigator. You'll also gain practical tips and resources to help you get started in research within community and academic settings.
Tune to the APSHO Research and Quality Improvement Forum for a webinar on Promoting AP involvement in Clinical Research: Highlighting Pathways in Community and Academic Settings with an expert panel of research advanced practitioners from a diverse group of organizations.
- Career Background: Journey of an oncology APP in clinical research.
- Daily Schedule: Integrating research into a typical workday.
- Tips and Resources: Practical tips for APPs to get involved in research.
The content of this webinar is presented by APSHO but does not necessarily reflect the views, opinions, or ideas of APSHO as an organization. The content has not been peer-reviewed and is not eligible for continuing education credits. APSHO is not responsible for any medical decisions made by attendees based on the information provided in this presentation. Any issues, concerns, or questions regarding the presentation should be directed to info@apsho.org.
Christa Braun-Inglis (Moderator)
DNP, APRN-Rx, FNP-BC, AOCNP
University of Hawaii Cancer Center
Christa Braun-Inglis was the first oncology nurse practitioner in the state of Hawaii. Dr. Braun-Inglis has been instrumental on the local and national level in expanding the role of advanced practice providers (APPs) in clinical trials. She has also advocated for cancer clinical trials in the community setting and diverse patient enrollment in clinical trials. With over 25 years of oncology nursing experience, she holds a dual role as both a nurse practitioner and an assistant researcher at the University of Hawaii Cancer Center in Honolulu, Hawaii. She is also a clinical faculty member at the University of Hawaii School of Nursing. Through her efforts, the National Cancer Institute (NCI) revised their policies in 2021, empowering APPs to fully exercise their credentials and enroll patients in supportive care trials. In 2023, she received the National Cancer Institute’s Director’s Award. In addition, she is also the current Chair of the Research and Quality Improvement committee of APSHO.
Christa Braun-Inglis has no relevant financial relationships to disclose.
Lisa A. Kottschade
APRN, MSN, CNP, FAPO, APSHO President
Mayo Clinic
Ms. Lisa A. Kottschade is an Associate Professor of Oncology and a Nurse Practitioner in the Melanoma and Cutaneous Oncology and Immunotherapy Toxicity Clinics at Mayo Clinic. Recently she was named the Chair of Research Committee for the Office of NP/PA in Rochester. She is the current President of APSHO as well as leads the Alliance Oncology Nursing Committee. Her clinical and research interests include those in the field of melanoma including its treatment and management of side effects from therapy with a special focus on those related to Immune Checkpoint Inhibitors.
Lisa A. Kottschade has no relevant financial relationships to disclose.
Mee-young Lee
MSN, ANP-BC, AOCNP
Dana-Farber Cancer Institute
Mee-young Lee is a nurse practitioner with over 25 years of oncology experience. She earned her MSN from the University of Pennsylvania in 2006 and has held clinical roles at Beth Israel Deaconess Medical Center, Northwell Health, and St. Francis Heart Hospital. She currently practices at Dana-Farber Cancer Institute, specializing in thoracic oncology. Mee-young is also an active member of the Research and Quality Improvement Committee of the Advanced Practitioner Society for Hematology and Oncology (APSHO).
Mee-young Lee has no relevant financial relationships to disclose.
Ashley Springer
MSN, AGPCNP-BC, APRN-Rx
Hawaii Cancer Care
Ashley received a Master of Science in nursing degree from University of Hawaii at Manoa. She has been a nurse practitioner in medical oncology and hematology for over 10 years. Ashley is a member of APSHO’s Research and Quality Initiative Task Force. She currently serves as co-chair for the CCDR/Symptom management disease site working group and member of the thoracic and hematology disease site working groups at the University of Hawaii Cancer Center. She has served as site PI for several CCDR/Symptom management clinical trials as well as serving as a non-physician investigator on cooperative group and industry therapeutic clinical trials. She also maintains an active role precepting nurse practitioner students.
Ashley Springer has no relevant financial relationships to disclose.
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Contains 3 Component(s)
Learn about fertility preservation in radiation oncology, including impacts, strategies, counseling, collaboration, and evidence-based guidelines.
Tune to the APSHO Radiation Oncology APP Network for a webinar on Fertility Preservation in Radiation Oncology: Counseling and Options with Emery Bergey, MBA, MSN, APRN, AGCNS-BC, OCN.
- Understand the impact of radiation on fertility
- Identify fertility preservation strategies
- Enhance counseling and shared decision-making skills
- Navigate multidisciplinary collaboration and referral pathways
- Apply evidence-based guidelines and institutional protocols
The content of this webinar is presented by APSHO but does not necessarily reflect the views, opinions, or ideas of APSHO as an organization. The content has not been peer-reviewed and is not eligible for continuing education credits. APSHO is not responsible for any medical decisions made by attendees based on the information provided in this presentation. Any issues, concerns, or questions regarding the presentation should be directed to info@apsho.org.
Emery Bergey (Moderator)
MBA, MSN, APRN, AGCNS-BC, OCN
Moffitt Cancer Center
Emery Bergey, MBA, MSN, APRN, AGCNS-BC, OCN, is a clinical nurse specialist and advanced practice provider in the department of Radiation Oncology at Moffitt Cancer Center in Tampa, Florida. She holds multiple advanced degrees and certifications, including a Master of Science in Nursing Education, an MBA, and a post-master’s certificate in advanced practice nursing. Emery has extensive experience in oncology nursing, Lean Six Sigma, and trauma-informed care. She has worked as a lead RN case manager at the University of Florida Proton Therapy Institute and is a National Innovation and Entrepreneurship Fellow. Emery is dedicated to advancing holistic care for adolescent and young adult oncology patients and advocating for oncofertility care.
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Contains 2 Component(s)
This module assists the learner to develop a manuscript for submission. The learner will learn to identify topics and develop manuscripts with useful tips provided by the faculty.
Manuscript Writing 101 covers essential steps from choosing a research topic to journal submission and peer review responses. This course was designed to help Advanced Practitioners master scientific writing, providing the tools and insights needed for successful publication. It is ideal for both beginners and those looking to refine their skills.
At the conclusion of this activity, participants will be able to:
- Discuss choosing the right research topic and journal
- Understand the manuscript submission process
- Navigating peer reviews and revisions
- Avoiding predatory journals
- Amanda Brink, DNP, APRN, FNP-BC, AOCNP
- Sandra Cuellar, PharmD, BCOP
- Cara Fleming, AGPCNP-BC, AOCNP
- Carolyn Grande, CRNP, AOCNP, FAPO
- Amber Koehler, PA-C
- Heather Lewin, MSN, APRN
- Gayathri Moorthy, PhD, APRN, AOCNP
- Nancy Nix, PharmD, BCPS, BCOP
- Anshika Singh, PharmD
- Gabriele Urschel, DNP, RN, FNP-C, AOCNP
- Constance Visovsky, PHD, RN, ACNP, FAAN
- Amelia Wodzinski, RN, CRNP, AOCNP
- Wendy Vogel, MSN, FNP, AOCNP, FAPO
- Heather Koniarczyk, MSN, APRN-CNP, AOCNP, FAPO
Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP
Clinical Associate Professor, Clinical Oncology Pharmacist
University of Illinois at Chicago (UIC), UI Health
Dr. Sandra Cuellar is a Clinical Associate Professor in the Department of Pharmacy Practice at the University of Illinois at Chicago (UIC) College of Pharmacy and a clinical oncology pharmacist at UI Health. She received her PharmD degree from the University of Illinois at Chicago College of Pharmacy and then completed a Pharmacy Practice Residency at University of Kentucky Chandler Medical Center. Following her residency, she completed a specialty oncology residency at MD Anderson Cancer Center in Houston. Dr. Cuellar is the director of the oncology residency program and chair of the IRB at UI Health. Dr. Cuellar is an editor at large for the Journal of Hematology Oncology Pharmacy and an invited lecturer to national organizations, including HOPA, ASHP, ACCP, ACCC, and AMCP. In addition, Dr. Cuellar was recently appointed to be a member of the ASHP Commission on Credentialing and past chair of the industry relation council for the Hematology Oncology Pharmacy Association.
-
Register
- Member - Free!
- More Information
-
Contains 5 Component(s)
This course covers the basics of cancer biology and genetics, including cancer characteristics, carcinogenesis, oncogenes, tumor suppressor genes, and cellular signaling pathways. It also addresses genetic testing for hereditary cancer syndromes and tumor genomic profiling, with insights into future developments, report information, and somatic variant–drug pairs.
This course provides a comprehensive exploration of cancer biology and genetics. It delves into the characteristics of cancer, the mechanisms of carcinogenesis, and the roles of oncogenes and tumor suppressor genes. Learners will gain insights into cellular signaling pathways and the genetic testing associated with hereditary cancer syndromes. The course also covers tumor genomic profiling, discussing its indications, various types, and future advancements. Additionally, it offers an in-depth look at the common information found in genomic reports and the interplay between somatic variants and drug pairs.
This activity qualifies as Category II Continuing Medical Education (CME) for Physician Assistants. Category II CME activities include any medically related activity that enhances the role of a PA and has not been designated for Category I CME credit. It is the responsibility of the participant to log Category II CME hours in accordance with NCCPA guidelines.
-
Register
- Member - Free!
- More Information
-
Register
-
Contains 2 Component(s)
Expert panel discussion highlighting practical solutions and best practices for current and future APPs in radiation oncology.
The APSHO Radiation Oncology Committee brings you the APSHO Radiation Oncology APP Network: APP Utilization in Radiation Oncology: Metrics, Challenges, and Best Practices lead by an expert panel on the following key topics:
- Successful Utilization Models and Challenges
- Balancing Clinical and Administrative Roles
- Performance Metrics and Quality Care Alignment
- Professional Development and Career Growth
- Navigating Regulatory and Institutional Hurdles
The content of this webinar is presented by APSHO but does not necessarily reflect the views, opinions, or ideas of APSHO as an organization. The content has not been peer-reviewed and is not eligible for continuing education credits. APSHO is not responsible for any medical decisions made by attendees based on the information provided in this presentation. Any issues, concerns, or questions regarding the presentation should be directed to info@apsho.org.
Katie Bukolt MSN, APRN, FNP-C, AOCNP (Moderator)
APP Area Manager-Dallas Sammons
Texas Oncology/ US Oncology
Kate Martin, PA-C
Senior manager of APPs for the Department of Radiation Oncology
Dana-Farber Brigham and Women's Cancer Center
Maitry Patel, MBA, BSC, BHSc(PA), CCPA
Manager of Clinical Operations
University Hospitals in Cleveland, Ohio
Molly Tate, APRN, FNP-C
AP Supervisor of Radiation Oncology
MD Anderson Cancer Center
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Contains 2 Component(s)
Tune in to stay updated with the latest advancements in hematology, oncology from the ASCO 2024 conference, and FDA drug approvals.
Tune in to stay updated with the latest advancements in hematology, oncology from the ASCO 2024 conference, and FDA drug approvals.
- Hematology Update from ASCO 2024: Discusses key findings in hematology, including new research and treatment approaches.
- Solid Tumor Oncology Update from ASCO 2024: Covers the latest in solid tumor treatments and their clinical implications.
- Drug Approval Updates: Reviews the newest drug approvals and their potential impact on patient care
By watching this webinar, advanced practitioners will gain critical insights into the latest research, innovative treatments, and new drug approvals, enhancing their ability to provide cutting-edge care to patients.
Katie Sellers (Moderator)
MPAS, PA-C
Texas Oncology, Dallas, TX
No relevant financialrelationships to disclose
Andrew Guinigundo (Moderator)
MSN, RN, CNP, ANP-BC, FAPO
Cincinnati Cancer Advisors, OH
Speakers’ Bureau: Amgen, Astellas, AstraZeneca, GSK, Natera,Pfizer
Consulting:Amgen, AstraZeneca
Megan May (Moderator)
PharmD, BCOP, FHOPA, FAPO
Baptist Health Lexington, KY
Advisory Board: Lilly, Genentech, Pfizer, AstraZeneca, Daiichi Sankyo, GlaxoSmithKline
Speakers’Bureau: Amgen, AstraZeneca
Consulting:Amgen, Lilly
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Contains 20 Product(s)
The Cancer Therapy Prescribing Course is a comprehensive, CE-accredited course for nurse practitioners, PAs, and pharmacists benchmarking the education that advanced practitioners need to safely prescribe cancer therapy. Topics include chemotherapy, targeted therapy, and immunotherapy prescribing best practices.
The Cancer Therapy Prescribing Course is a comprehensive, CE-accredited course for nurse practitioners, PAs, and pharmacists benchmarking the education that advanced practitioners need to safely prescribe cancer therapy. Topics include chemotherapy, targeted therapy, and immunotherapy prescribing best practices.
This course was developed by the Advanced Practitioner Society for Hematology and Oncology (APSHO). Any recommendations contained in this course reflect APSHO's or Harborside's judgement regarding the state of general knowledge and practice in the field as of the date of publication. The recommendations may not be appropriate for use in all circumstances. APSHO and Harborside neither represent nor guarantee that the practices described herein will, if followed, ensure safe and effective patient care. Every healthcare provider should make their own determination regarding specific safe and appropriate patient care practices, including drug dosages and indications, considering patient specific characteristics, institutional policies and procedures, personnel, and equipment. The provider should always consult the most recent prescribing/product information. Though APSHO and the content creators have applied a rigorous review process to produce an error-free module, inadvertent mistakes can occur during the writing/editing/proofreading process. Information is not guaranteed to be accurate, complete, or current. APSHO, its editors, authors and reviewers cannot be held responsible for any liability incurred as a consequence for the application of any of the contents of this course contents. Figures and tables are used as examples and are not meant to be all-inclusive, nor do they represent endorsement of any particular therapy or institution. Websites mentioned are provided for information only and the website hosts are responsible for their own content and availability.
-
Register
- Non-member - $625
- Member - $500
- More Information
-
Register
-
Contains 2 Component(s) Recorded On: 08/21/2024
Gain insights into the latest diagnostic radiology techniques and their applications in radiation oncology.
Key Takeaways:
- Understanding the role of diagnostic radiology in treatment planning and patient management
- Learning about advanced imaging modalities and their impact on radiation therapy
- Enhancing skills in interpreting radiologic findings relevant to radiation oncology
The content of this webinar is presented by APSHO but does not necessarily reflect the views, opinions, or ideas of APSHO as an organization. The content has not been peer-reviewed and is not eligible for continuing education credits. APSHO is not responsible for any medical decisions made by attendees based on the information provided in this presentation. Any issues, concerns, or questions regarding the presentation should be directed to info@apsho.org.
Katie Bukolt MSN, APRN, FNP-C, AOCNP (Moderator)
APP Area Manager-Dallas Sammons
Texas Oncology/ US Oncology
Jonathan Moonen, APRN, CNP, DNP
Mayo Clinic in Rochester, Minnesota
Molly Tate, APRN, FNP-C
AP Supervisor of Radiation Oncology
MD Anderson Cancer Center
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Contains 2 Component(s)
This module assists the learner to develop an abstract for submission to a professional conference. The learner will learn to identify topics and develop abstracts with useful tips provided by the faculty.
This module assists the learner to develop an abstract for submission to a professional conference. The learner will learn to identify topics and develop abstracts with useful tips provided by the faculty.
At the conclusion of this activity, participants will be able to:
- Identify potential categories for abstract topics
- Explain the purpose of an abstract
- Describe useful tips and common pitfalls of writing an abstract
- Deirdre Casey, MSN, RN, AGACNP-BC
- Ashley Glode, PharmD, BCOP, FHOPA
- Carolyn Grande, CRNP, AOCNP, FAPO
- Charlene Kabel, PharmD, BCOP
- Heather Lewin, APRN, MSN
- Nancy Nix, PharmD, BCPS, BCOP
- Tammy Triglianos, DNP, ANP-BC, AOCNP
Nancy Nix, PharmD, BCPS, BCOP
Senior Medical Science Liaison
Bayer, USMA Genitourinary Oncology
-
Register
- Member - Free!
- More Information
-
Contains 13 Product(s)
The Safely Prescribing Controlled Substances in Oncology modules by APSHO include 13 comprehensive, and self-paced modules, thoughtfully crafted to equip you with the knowledge and expertise necessary to safely prescribe controlled substances and to understand and manage substance use disorders in the hematology/oncology setting. 9 CE-Accredited Hours (3.5 pharmacology hours for ANCC accreditation)
The Safely Prescribing Controlled Substances in Oncology modules by APSHO include 13 comprehensive, and self-paced modules, thoughtfully crafted to equip you with the knowledge and expertise necessary to safely prescribe controlled substances and to understand and manage substance use disorders in the hematology/oncology setting. (These modules will meet the DEA requirement for 8 hours of training on substance use disorder.) 9 CE-Accredited Hours (3.5 pharmacology hours for ANCC accreditation)
-
Register
- Non-member - $75
- Member - Free!
- More Information
-
Register